Kevin Hakimi, MD
@kevinhakimi23
PGY-2 @USC_Urology
ID: 63775090
07-08-2009 17:06:35
1,1K Tweet
421 Followers
678 Following
Bottom surgery improves HRQOL to POPULATION LEVELS!! Great work by Kevin Hakimi, MD . Congrats on Best Poster! USC Urology is lucky to have you UCSD Urology #WPATH #AUA2023
Delighted our work on HRQOL following gender affirming pelvic surgery was selected as best poster at the #AUA23 health services research session. Big thank you to my amazing mentor Jennifer Anger, MD, MPH! Bottom surgery improves HRQOL to the normal range. More to come!
Andrea Merrill, MD FACS Yeonsoo Sara Lee, MD fabrizio dal moro And while you are looking for talents outside of the operating room - I must tell you about the amazing musical skills of Kevin Hakimi, MD and Manoj Monga - they even inspired some tiny rock stars in the process!
Walked out of step 2 today to see that our post-IO project was published!! Thank you to all of the amazing people that made this happen. Rana McKay, MD, FASCO Ava Saidian Kevin Hakimi, MD Ithaar H. Derweesh academic.oup.com/oncolo/advance…
It was a great day at sea 🌊 actually for the annual planning session for the PGY1&2’s with Dr Gerhard Fuchs & PC Shannon Michael Sadighian, MD Kevin Hakimi, MD Jordan Saunders, MD Austin Leonard Amer. Urol. Assn. UroSoMe Urology Match Keck School of Medicine of USC Los Angeles General Medical Center #uscurology
Hot off the press! Excited to have this work published, thank you to all our collaborators! Ithaar H. Derweesh Rana McKay, MD, FASCO Justine Panian, MD Ava Saidian clinical-genitourinary-cancer.com/article/S1558-…
Just Published: PADRES: Phase 2 Clinical Trial of Neoadjuvant Axitinib for Complex Partial Nephrectomy Ithaar H. Derweesh Kevin Hakimi, MD doi.org/10.1111/bju.16…
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy by Kevin Hakimi, MD Ithaar H. Derweesh et al - read online now doi.org/10.1111/bju.16…